Dynavax Technologies
DVAX
DVAX was delisted on the 9th of February, 2026.
117 hedge funds and large institutions have $388M invested in Dynavax Technologies in 2013 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 19 reducing their positions, and 10 closing their positions.
190% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 10
184% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 19
169% more capital invested
Capital invested by funds: $144M → $388M (+$244M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
19% more funds holding
Funds holding: 98 → 117 (+19)
23% less call options, than puts
Call options by funds: $433K | Put options by funds: $560K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$17.4M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$16.9M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$13.5M |
| 4 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$11.7M |
| 5 |
BC
Broadfin Capital
New York
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$10.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.51M |
| 3 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$4.56M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$355K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$264K |
DVAX Hedge Fund Activity: Q4 2013 in Review
117 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q4 2013, worth a combined $388M — up 169% from $144M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new DVAX positions and 10 closed out — a net gain of 19 holders — while 54 added to existing stakes and 19 trimmed.
The largest buyer was RA Capital Management, adding an estimated $17.4M. The largest seller was OrbiMed, exiting entirely with an estimated $10.7M sold.
- 117 institutional investors held Dynavax Technologies (DVAX) as of Q4 2013, up from 98 in Q3 2013.
- Funds reported $388M of Dynavax Technologies stock for Q4 2013, up 169% quarter-over-quarter.
- 29 funds opened new Dynavax Technologies positions in Q4 2013 and 10 closed out, a net change of +19 holders.
- The largest Dynavax Technologies buyer in Q4 2013 was RA Capital Management, an estimated $17.4M added.
- The largest Dynavax Technologies seller in Q4 2013 was OrbiMed, an estimated $10.7M sold.
Based on aggregated 13F filings for Q4 2013.